Metrics as of 10/16/2026, 06:46 AM (Berlin time), refresh in progress.
DarioHealth Stock
DarioHealth Corp.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Erez Raphael
- Employees
- 163
- Market cap
- $50 M
- IPO
- 14/03/2016
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight…
DarioHealth stock: price history
1D
-5.9%
1W
-5.5%
1M
-24.0%
6M
-27.0%
YTD
-54.9%
1Y
-62.0%
2Y
-74.4%
5Y
-98.4%
10Y
-99.7%
Next earnings date
Next earnings date
12/11/2026 (in 26 days)
Volatility around earnings
~22% stronger price swings than usual
Ask the agents about DarioHealth
Analyst assessment of DarioHealth
PRICE TARGET LOW
US$7.50
CONSENSUS
US$12.50
MEDIAN
US$14.00
PRICE TARGET HIGH
US$16.00
0
STRONG BUY
8
BUY
1
HOLD
0
SELL
0
STRONG SELL
9
TOTAL · Buy
As of: 12/08/2026
DarioHealth stock metrics
P/E
7.43
P/B
0.87
EV/EBITDA
-2.56
RETURN ON EQUITY
-14.4%
NET MARGIN
-153.1%
DEBT/EQUITY
0.59
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
70.5%
FLOAT SHARES
6,908,340
AVG. DAILY VOLUME (30D)
19,464
Insider transactions (SEC)
PALUMBO JOHN R
STERN ADAM K
STERN ADAM K
Raphael Erez
Raphael Erez
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about DarioHealth stock
What does DarioHealth do?
DarioHealth Corp. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Erez Raphael, the company employs around 163 people.
The IPO was on 14/03/2016; the stock trades on NASDAQ under the ticker DRIO.
What do analysts say about DarioHealth stock?
9 analysts rate the stock, the consensus is Buy (as of 12/08/2026).
The average price target is US$12.50, ranging from US$7.50 to US$16.00, with a median of US$14.00.
This is an external assessment, not a statement by Market Jury.
When does DarioHealth report next?
The next earnings date is 12/11/2026.
Around past earnings, price swings were roughly 22% stronger than usual.
Does DarioHealth pay a dividend?
No, DarioHealth currently does not pay a dividend.
Which stocks are comparable to DarioHealth?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get DarioHealth stock analyzed?
Clicking "Analyze stock" lets five strategies assess DarioHealth against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.